AVB vs BTAI · P/E 23, rev $3.04B vs rev $388.0K
AvalonBay Communities Inc (AVB) versus BioXcel Therapeutics Inc (BTAI) — a side-by-side from cached financials, not a winner call.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AVB revenue for 2025-12-31 was $3.04B. Net income was $1.06B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
AVB currently screens at market cap $26.84B and trailing P/E 23.4. BTAI currently screens at market cap $36.1M.
Not investment advice. Open the AVB and BTAI stock pages for the full models.
Not investment advice.